Product NDC: | 0004-0298 |
Proprietary Name: | CellCept |
Non Proprietary Name: | Mycophenolate Mofetil hydrochloride |
Active Ingredient(s): | 500 mg/20mL & nbsp; Mycophenolate Mofetil hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0004-0298 |
Labeler Name: | Genentech, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050758 |
Marketing Category: | NDA |
Start Marketing Date: | 19981001 |
Package NDC: | 0004-0298-09 |
Package Description: | 4 VIAL in 1 CARTON (0004-0298-09) > 20 mL in 1 VIAL |
NDC Code | 0004-0298-09 |
Proprietary Name | CellCept |
Package Description | 4 VIAL in 1 CARTON (0004-0298-09) > 20 mL in 1 VIAL |
Product NDC | 0004-0298 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mycophenolate Mofetil hydrochloride |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19981001 |
Marketing Category Name | NDA |
Labeler Name | Genentech, Inc. |
Substance Name | MYCOPHENOLATE MOFETIL HYDROCHLORIDE |
Strength Number | 500 |
Strength Unit | mg/20mL |
Pharmaceutical Classes | Antimetabolite Immunosuppressant [EPC] |